These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 28576280)

  • 41. Screening and management of familial hypercholesterolemia.
    Santos RD
    Curr Opin Cardiol; 2019 Sep; 34(5):526-530. PubMed ID: 31393421
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical determinants and treatment gaps in familial hypercholesterolemia: Data from a multi-ethnic regional health service.
    Zafrir B; Jubran A; Lavie G; Halon DA; Flugelman MY; Shapira C
    Eur J Prev Cardiol; 2017 May; 24(8):867-875. PubMed ID: 28186442
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A xanthomatosis-susceptibility gene may exist in a Syrian family with familial hypercholesterolemia.
    Vergopoulos A; Bajari T; Jouma M; Knoblauch H; Aydin A; Bähring S; Mueller-Myhsok B; Dresel A; Joubran R; Luft FC; Schuster H
    Eur J Hum Genet; 1997; 5(5):315-23. PubMed ID: 9412789
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence of high cholesterol levels suggestive of familial hypercholesterolemia in Brazilian adolescents: Data from the study of cardiovascular risk in adolescents.
    Kaestner TL; Bento VF; Pazin DC; Baena CP; Olandoski M; Abreu GA; Kuschnir MCC; Bloch KV; Faria-Neto JR
    J Clin Lipidol; 2018; 12(2):403-408. PubMed ID: 29429893
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Familial hypercholesterolemia in the danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication.
    Benn M; Watts GF; Tybjaerg-Hansen A; Nordestgaard BG
    J Clin Endocrinol Metab; 2012 Nov; 97(11):3956-64. PubMed ID: 22893714
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Elevated lipoprotein(a), hypertension and renal insufficiency as predictors of coronary artery disease in patients with genetically confirmed heterozygous familial hypercholesterolemia.
    Chan DC; Pang J; Hooper AJ; Burnett JR; Bell DA; Bates TR; van Bockxmeer FM; Watts GF
    Int J Cardiol; 2015 Dec; 201():633-8. PubMed ID: 26340131
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Familial hypercholesterolemia and estimation of US patients eligible for low-density lipoprotein apheresis after maximally tolerated lipid-lowering therapy.
    Vishwanath R; Hemphill LC
    J Clin Lipidol; 2014; 8(1):18-28. PubMed ID: 24528684
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Two novel mutations in exon 3 and 4 of low density lipoprotein (LDL) receptor gene in patients with heterozygous familial hypercholesterolemia.
    Khan SP; Ghani R; Ahmed KZ; Yaqoob Z
    J Coll Physicians Surg Pak; 2011 Jul; 21(7):403-6. PubMed ID: 21777527
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [A Family History of Hypercholesterolemia - the Role of Genetics].
    Podmore C; Deillon E; Nanchen D
    Praxis (Bern 1994); 2023; 112(4):245-249. PubMed ID: 36919320
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Low-density lipoprotein cholesterol-lowering effects of AMG 145, a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 serine protease in patients with heterozygous familial hypercholesterolemia: the Reduction of LDL-C with PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder (RUTHERFORD) randomized trial.
    Raal F; Scott R; Somaratne R; Bridges I; Li G; Wasserman SM; Stein EA
    Circulation; 2012 Nov; 126(20):2408-17. PubMed ID: 23129602
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The challenge produced by familial homozygous hypercholesterolemia when treating premature coronary arterial disease in the young.
    Shankarappa RK; Moorthy N; Bhat SP; Dwarakaprasad R; Nanjappa MC
    Cardiol Young; 2009 Jun; 19(3):257-63. PubMed ID: 19344536
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of lomitapide on cardiovascular outcome measures in homozygous familial hypercholesterolemia: A modelling analysis.
    Leipold R; Raal F; Ishak J; Hovingh K; Phillips H
    Eur J Prev Cardiol; 2017 Nov; 24(17):1843-1850. PubMed ID: 28925748
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study.
    Pirillo A; Garlaschelli K; Arca M; Averna M; Bertolini S; Calandra S; Tarugi P; Catapano AL;
    Atheroscler Suppl; 2017 Oct; 29():17-24. PubMed ID: 28965616
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Screening for familial hypercholesterolaemia in primary care: Time for general practice to play its part.
    Brett T; Qureshi N; Gidding S; Watts GF
    Atherosclerosis; 2018 Oct; 277():399-406. PubMed ID: 30270077
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Evaluation of knowledge and practices regarding heterozygous familial hypercholesterolemia in children].
    Jeangeorges A; Rubio A
    Arch Pediatr; 2018 Feb; 25(2):107-111. PubMed ID: 29248321
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Child-Parent Familial Hypercholesterolemia Screening in Primary Care.
    Wald DS; Bestwick JP; Morris JK; Whyte K; Jenkins L; Wald NJ
    N Engl J Med; 2016 Oct; 375(17):1628-1637. PubMed ID: 27783906
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review.
    Austin MA; Hutter CM; Zimmern RL; Humphries SE
    Am J Epidemiol; 2004 Sep; 160(5):407-20. PubMed ID: 15321837
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and Safety of Alirocumab in Japanese Patients With Heterozygous Familial Hypercholesterolemia or at High Cardiovascular Risk With Hypercholesterolemia Not Adequately Controlled With Statins　- ODYSSEY JAPAN Randomized Controlled Trial.
    Teramoto T; Kobayashi M; Tasaki H; Yagyu H; Higashikata T; Takagi Y; Uno K; Baccara-Dinet MT; Nohara A
    Circ J; 2016 Aug; 80(9):1980-7. PubMed ID: 27452202
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cascade Screening in Familial Hypercholesterolemia: Advancing Forward.
    Santos RD; Frauches TS; Chacra AP
    J Atheroscler Thromb; 2015; 22(9):869-80. PubMed ID: 26194978
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Familial hypercholesterolemia: a challenge of diagnosis and therapy.
    Sibley C; Stone NJ
    Cleve Clin J Med; 2006 Jan; 73(1):57-64. PubMed ID: 16444917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.